| Characteristic | Japan | Europe | United States | South Korea | China | India | Turkey | Others |
|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
April 2018
More information
Region
Worldwide
Survey time period
2013 to 2017
Supplementary notes
* Revenues in 2015 include Q CELLS’ revenues from January 1 through February 5, 2015 and consolidated revenues from February 6 through December 31, 2015.
** Turkey has been merged into the Others category for years prior to 2015, due to the small revenue generated by the country. The source provides that in 2014, Hanwha Q-Cells generated 0.3 million U.S. dollars in Turkey.
Citation formats
